Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | ß-Blockers | Research

Association between initial in-hospital heart rate and glycemic control in patients with acute ischemic stroke and diabetes mellitus

Authors: Ya-Wen Kuo, Jiann-Der Lee, Chuan-Pin Lee, Yen-Chu Huang, Meng Lee

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

A high resting heart rate (HR) has been associated with an increased risk of diabetes mellitus. This study explored the association between initial in-hospital HR and glycemic control in patients with acute ischemic stroke (AIS) and diabetes mellitus.

Methods

We analyzed data from 4,715 patients with AIS and type 2 diabetes mellitus enrolled in the Chang Gung Research Database between January 2010 and September 2018. The study outcome was unfavorable glycemic control, defined as glycated hemoglobin (HbA1c) ≥ 7%. In statistical analyses, the mean initial in-hospital HR was used as both a continuous and categorical variable. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression analysis. The associations between the HR subgroups and HbA1c levels were analyzed using a generalized linear model.

Results

Compared with the reference group (HR < 60 bpm), the adjusted ORs for unfavorable glycemic control were 1.093 (95% CI 0.786–1.519) for an HR of 60–69 bpm, 1.370 (95% CI 0.991–1.892) for an HR of 70–79 bpm, and 1.608 (95% CI 1.145–2.257) for an HR of ≥ 80 bpm. Even after adjusting for possible confounders, the HbA1c levels after admission and discharge among diabetic stroke patients increased significantly in the subgroups with higher HRs (p < 0.001).

Conclusions

High initial in-hospital HR is associated with unfavorable glycemic control in patients with AIS and diabetes mellitus, particularly in those with an HR of ≥ 80 bpm, compared with those with an HR of < 60 bpm.
Literature
1.
go back to reference Osei E, Fonville S, Zandbergen AA, Koudstaal PJ, Dippel DW, den Hertog HM. Glucose in prediabetic and diabetic range and outcome after stroke. Acta Neurol Scand. 2017;135(2):170–5.PubMedCrossRef Osei E, Fonville S, Zandbergen AA, Koudstaal PJ, Dippel DW, den Hertog HM. Glucose in prediabetic and diabetic range and outcome after stroke. Acta Neurol Scand. 2017;135(2):170–5.PubMedCrossRef
2.
go back to reference Giorgino F, Leonardini A, Laviola L. Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. Ann N Y Acad Sci. 2013;1281:36–50.PubMedPubMedCentralCrossRef Giorgino F, Leonardini A, Laviola L. Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. Ann N Y Acad Sci. 2013;1281:36–50.PubMedPubMedCentralCrossRef
3.
go back to reference American Diabetes A. 6. Glycemic targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):66–S76.CrossRef American Diabetes A. 6. Glycemic targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):66–S76.CrossRef
4.
go back to reference Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, et al. 2021 Guideline for the Prevention of Stroke in patients with stroke and transient ischemic attack: a Guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467.PubMedCrossRef Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, et al. 2021 Guideline for the Prevention of Stroke in patients with stroke and transient ischemic attack: a Guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467.PubMedCrossRef
5.
go back to reference del Canizo-Gomez FJ, Moreira-Andres MN. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines? Diabetes Res Clin Pract. 2004;65(2):125–33.PubMedCrossRef del Canizo-Gomez FJ, Moreira-Andres MN. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines? Diabetes Res Clin Pract. 2004;65(2):125–33.PubMedCrossRef
6.
go back to reference Zhang X, Shu XO, Xiang YB, Yang G, Li H, Cai H, Gao YT, Zheng W. Resting heart rate and risk of type 2 diabetes in women. Int J Epidemiol. 2010;39(3):900–6.PubMedPubMedCentralCrossRef Zhang X, Shu XO, Xiang YB, Yang G, Li H, Cai H, Gao YT, Zheng W. Resting heart rate and risk of type 2 diabetes in women. Int J Epidemiol. 2010;39(3):900–6.PubMedPubMedCentralCrossRef
7.
go back to reference Li YQ, Sun CQ, Li LL, Wang L, Guo YR, You AG, Xi YL, Wang CJ. Resting heart rate as a marker for identifying the risk of undiagnosed type 2 diabetes mellitus: a cross-sectional survey. BMC Public Health. 2014;14:1052.PubMedPubMedCentralCrossRef Li YQ, Sun CQ, Li LL, Wang L, Guo YR, You AG, Xi YL, Wang CJ. Resting heart rate as a marker for identifying the risk of undiagnosed type 2 diabetes mellitus: a cross-sectional survey. BMC Public Health. 2014;14:1052.PubMedPubMedCentralCrossRef
8.
go back to reference Kim G, Lee YH, Jeon JY, Bang H, Lee BW, Kang ES, Lee IK, Cha BS, Kim CS. Increase in resting heart rate over 2 years predicts incidence of diabetes: a 10-year prospective study. Diabetes Metab. 2017;43(1):25–32.PubMedCrossRef Kim G, Lee YH, Jeon JY, Bang H, Lee BW, Kang ES, Lee IK, Cha BS, Kim CS. Increase in resting heart rate over 2 years predicts incidence of diabetes: a 10-year prospective study. Diabetes Metab. 2017;43(1):25–32.PubMedCrossRef
9.
go back to reference Xu C, Zhong J, Zhu H, Hu R, Fang L, Wang M, Zhang J, Guo Y, Bian Z, Chen Z, et al. Independent and interactive associations of heart rate and body mass index or blood pressure with type 2 diabetes mellitus incidence: a prospective cohort study. J Diabetes Investig. 2019;10(4):1068–74.PubMedPubMedCentralCrossRef Xu C, Zhong J, Zhu H, Hu R, Fang L, Wang M, Zhang J, Guo Y, Bian Z, Chen Z, et al. Independent and interactive associations of heart rate and body mass index or blood pressure with type 2 diabetes mellitus incidence: a prospective cohort study. J Diabetes Investig. 2019;10(4):1068–74.PubMedPubMedCentralCrossRef
10.
go back to reference Valensi P, Extramiana F, Lange C, Cailleau M, Haggui A, Maison Blanche P, Tichet J, Balkau B, Group DS. Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study. Diabet Med. 2011;28(4):440–9.PubMedCrossRef Valensi P, Extramiana F, Lange C, Cailleau M, Haggui A, Maison Blanche P, Tichet J, Balkau B, Group DS. Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study. Diabet Med. 2011;28(4):440–9.PubMedCrossRef
11.
go back to reference Torchinsky MY, Gomez R, Rao J, Vargas A, Mercante DE, Chalew SA. Poor glycemic control is associated with increased diastolic blood pressure and heart rate in children with type 1 diabetes. J Diabetes Complications. 2004;18(4):220–3.PubMedCrossRef Torchinsky MY, Gomez R, Rao J, Vargas A, Mercante DE, Chalew SA. Poor glycemic control is associated with increased diastolic blood pressure and heart rate in children with type 1 diabetes. J Diabetes Complications. 2004;18(4):220–3.PubMedCrossRef
12.
go back to reference Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS, Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Research G. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 2007, 30(8):2107–2112. Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS, Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Research G. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 2007, 30(8):2107–2112.
13.
go back to reference Tsai MS, Lin MH, Lee CP, Yang YH, Chen WC, Chang GH, Tsai YT, Chen PC, Tsai YH. Chang Gung Research Database: a multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263–9.PubMedPubMedCentralCrossRef Tsai MS, Lin MH, Lee CP, Yang YH, Chen WC, Chang GH, Tsai YT, Chen PC, Tsai YH. Chang Gung Research Database: a multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263–9.PubMedPubMedCentralCrossRef
14.
go back to reference Lee JD, Kuo YW, Lee CP, Huang YC, Lee M, Lee TH. Initial in-hospital heart rate is associated with long-term survival in patients with acute ischemic stroke.Clin Res Cardiol2021. Lee JD, Kuo YW, Lee CP, Huang YC, Lee M, Lee TH. Initial in-hospital heart rate is associated with long-term survival in patients with acute ischemic stroke.Clin Res Cardiol2021.
15.
go back to reference American Diabetes A. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):15–S33.CrossRef American Diabetes A. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):15–S33.CrossRef
16.
go back to reference Sung SF, Hsieh CY, Lin HJ, Chen YW, Chen CH, Kao Yang YH, Hu YH. Validity of a stroke severity index for administrative claims data research: a retrospective cohort study. BMC Health Serv Res. 2016;16(1):509.PubMedPubMedCentralCrossRef Sung SF, Hsieh CY, Lin HJ, Chen YW, Chen CH, Kao Yang YH, Hu YH. Validity of a stroke severity index for administrative claims data research: a retrospective cohort study. BMC Health Serv Res. 2016;16(1):509.PubMedPubMedCentralCrossRef
17.
go back to reference Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–70.PubMedCrossRef Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–70.PubMedCrossRef
18.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.PubMedCrossRef
19.
go back to reference Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, Lai MS. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn J Clin Oncol. 2015;45(3):291–6.PubMedCrossRef Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, Lai MS. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn J Clin Oncol. 2015;45(3):291–6.PubMedCrossRef
20.
go back to reference Standards of Medical Care in Diabetes-2017. Summary of revisions. Diabetes Care. 2017;40(Suppl 1):4–S5. Standards of Medical Care in Diabetes-2017. Summary of revisions. Diabetes Care. 2017;40(Suppl 1):4–S5.
22.
go back to reference Hansen CS, Faerch K, Jorgensen ME, Malik M, Witte DR, Brunner EJ, Tabak AG, Kivimaki M, Vistisen D. Heart rate, autonomic function, and future changes in glucose metabolism in individuals without diabetes: the Whitehall II Cohort Study. Diabetes Care. 2019;42(5):867–74.PubMedPubMedCentralCrossRef Hansen CS, Faerch K, Jorgensen ME, Malik M, Witte DR, Brunner EJ, Tabak AG, Kivimaki M, Vistisen D. Heart rate, autonomic function, and future changes in glucose metabolism in individuals without diabetes: the Whitehall II Cohort Study. Diabetes Care. 2019;42(5):867–74.PubMedPubMedCentralCrossRef
23.
go back to reference Yang Z, Zhang W, Zhu L, Lin N, Niu Y, Li X, Lu S, Zhang H, Wang X, Wen J, et al. Resting heart rate and impaired glucose regulation in middle-aged and elderly chinese people: a cross-sectional analysis. BMC Cardiovasc Disord. 2017;17(1):246.PubMedPubMedCentralCrossRef Yang Z, Zhang W, Zhu L, Lin N, Niu Y, Li X, Lu S, Zhang H, Wang X, Wen J, et al. Resting heart rate and impaired glucose regulation in middle-aged and elderly chinese people: a cross-sectional analysis. BMC Cardiovasc Disord. 2017;17(1):246.PubMedPubMedCentralCrossRef
24.
go back to reference Bonnet F, Empana JP, Natali A, Monti L, Golay A, Lalic K, Dekker J, Mari A, Balkau B, Group RS. Elevated heart rate predicts beta cell function in non-diabetic individuals: the RISC cohort. Eur J Endocrinol. 2015;173(3):409–15.PubMedCrossRef Bonnet F, Empana JP, Natali A, Monti L, Golay A, Lalic K, Dekker J, Mari A, Balkau B, Group RS. Elevated heart rate predicts beta cell function in non-diabetic individuals: the RISC cohort. Eur J Endocrinol. 2015;173(3):409–15.PubMedCrossRef
25.
go back to reference Festa A, D’Agostino R Jr, Hales CN, Mykkanen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000;23(5):624–8.PubMedCrossRef Festa A, D’Agostino R Jr, Hales CN, Mykkanen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000;23(5):624–8.PubMedCrossRef
26.
go back to reference Casagrande SS, Cowie CC, Sosenko JM, Mizokami-Stout K, Boulton AJM, Pop-Busui R. The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys.J Clin Endocrinol Metab2020, 105(3). Casagrande SS, Cowie CC, Sosenko JM, Mizokami-Stout K, Boulton AJM, Pop-Busui R. The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys.J Clin Endocrinol Metab2020, 105(3).
27.
go back to reference Kenney WL. Parasympathetic control of resting heart rate: relationship to aerobic power. Med Sci Sports Exerc. 1985;17(4):451–5.PubMedCrossRef Kenney WL. Parasympathetic control of resting heart rate: relationship to aerobic power. Med Sci Sports Exerc. 1985;17(4):451–5.PubMedCrossRef
28.
go back to reference Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab. 2011;13(Suppl 1):82–8.PubMedCrossRef Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab. 2011;13(Suppl 1):82–8.PubMedCrossRef
29.
go back to reference Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284(4):E671–678.PubMedCrossRef Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284(4):E671–678.PubMedCrossRef
30.
31.
go back to reference Brito JO, Ponciano K, Figueroa D, Bernardes N, Sanches IC, Irigoyen MC, De Angelis K. Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats. Braz J Med Biol Res. 2008;41(9):804–8.PubMedCrossRef Brito JO, Ponciano K, Figueroa D, Bernardes N, Sanches IC, Irigoyen MC, De Angelis K. Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats. Braz J Med Biol Res. 2008;41(9):804–8.PubMedCrossRef
32.
go back to reference Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010;95(5):2458–66.PubMedCrossRef Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010;95(5):2458–66.PubMedCrossRef
33.
go back to reference Keshavarzi S, Braffett BH, Pop-Busui R, Orchard TJ, Soliman EZ, Lorenzi GM, Barnie A, Karger AB, Gubitosi-Klug RA, Dagogo-Jack S, et al. Risk factors for longitudinal resting heart rate and its Associations with Cardiovascular Outcomes in the DCCT/EDIC study. Diabetes Care. 2021;44(5):1125–32.PubMedPubMedCentralCrossRef Keshavarzi S, Braffett BH, Pop-Busui R, Orchard TJ, Soliman EZ, Lorenzi GM, Barnie A, Karger AB, Gubitosi-Klug RA, Dagogo-Jack S, et al. Risk factors for longitudinal resting heart rate and its Associations with Cardiovascular Outcomes in the DCCT/EDIC study. Diabetes Care. 2021;44(5):1125–32.PubMedPubMedCentralCrossRef
34.
go back to reference Schmieder RE, Bramlage P, Haller H, Ruilope LM, Bohm M, Investigators R. The effect of resting heart rate on the New Onset of Microalbuminuria in patients with type 2 diabetes: a subanalysis of the ROADMAP Study. Med (Baltim). 2016;95(15):e3122.CrossRef Schmieder RE, Bramlage P, Haller H, Ruilope LM, Bohm M, Investigators R. The effect of resting heart rate on the New Onset of Microalbuminuria in patients with type 2 diabetes: a subanalysis of the ROADMAP Study. Med (Baltim). 2016;95(15):e3122.CrossRef
35.
go back to reference Liang DL, Li XY, Wang L, Xu H, Tuo XP, Jian ZJ, Wang XN, Yun JL, Zhang X, Wang SY. [Correlation between resting heart rate and blood glucose level in elderly patients with coronary heart disease and diabetes mellitus]. Nan Fang Yi Ke Da Xue Xue Bao. 2016;36(5):609–16.PubMed Liang DL, Li XY, Wang L, Xu H, Tuo XP, Jian ZJ, Wang XN, Yun JL, Zhang X, Wang SY. [Correlation between resting heart rate and blood glucose level in elderly patients with coronary heart disease and diabetes mellitus]. Nan Fang Yi Ke Da Xue Xue Bao. 2016;36(5):609–16.PubMed
36.
go back to reference Wai B, Kearney LG, Hare DL, Ord M, Burrell LM, Srivastava PM. Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control. Cardiovasc Diabetol. 2012;11:14.PubMedPubMedCentralCrossRef Wai B, Kearney LG, Hare DL, Ord M, Burrell LM, Srivastava PM. Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control. Cardiovasc Diabetol. 2012;11:14.PubMedPubMedCentralCrossRef
37.
go back to reference Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 1991;14(3):203–9.PubMedCrossRef Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 1991;14(3):203–9.PubMedCrossRef
38.
go back to reference Fonseca VA. Effects of beta-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010;26(3):615–29.PubMedCrossRef Fonseca VA. Effects of beta-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010;26(3):615–29.PubMedCrossRef
39.
go back to reference Mills GA, Horn JR. Beta-blockers and glucose control. Drug Intell Clin Pharm. 1985;19(4):246–51.PubMed Mills GA, Horn JR. Beta-blockers and glucose control. Drug Intell Clin Pharm. 1985;19(4):246–51.PubMed
40.
go back to reference Hirst JA, Farmer AJ, Feakins BG, Aronson JK, Stevens RJ. Quantifying the effects of diuretics and beta-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;79(5):733–43.PubMedPubMedCentralCrossRef Hirst JA, Farmer AJ, Feakins BG, Aronson JK, Stevens RJ. Quantifying the effects of diuretics and beta-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;79(5):733–43.PubMedPubMedCentralCrossRef
41.
go back to reference Del Rio G, Procopio M, Bondi M, Marrama P, Menozzi R, Oleandri SE, Grottoli S, Maccario M, Velardo A, Ghigo E. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord. 1997;21(12):1111–4.PubMedCrossRef Del Rio G, Procopio M, Bondi M, Marrama P, Menozzi R, Oleandri SE, Grottoli S, Maccario M, Velardo A, Ghigo E. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord. 1997;21(12):1111–4.PubMedCrossRef
42.
go back to reference Consolim-Colombo FM, Sangaleti CT, Costa FO, Morais TL, Lopes HF, Motta JM, Irigoyen MC, Bortoloto LA, Rochitte CE, Harris YT et al. Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.JCI Insight2017, 2(14). Consolim-Colombo FM, Sangaleti CT, Costa FO, Morais TL, Lopes HF, Motta JM, Irigoyen MC, Bortoloto LA, Rochitte CE, Harris YT et al. Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.JCI Insight2017, 2(14).
43.
go back to reference Ali MA, El-Abhar HS, Kamel MA, Attia AS. Antidiabetic effect of Galantamine: Novel Effect for a known centrally acting drug. PLoS ONE. 2015;10(8):e0134648.PubMedPubMedCentralCrossRef Ali MA, El-Abhar HS, Kamel MA, Attia AS. Antidiabetic effect of Galantamine: Novel Effect for a known centrally acting drug. PLoS ONE. 2015;10(8):e0134648.PubMedPubMedCentralCrossRef
44.
go back to reference Nguyen T, Wen S, Gong M, Yuan X, Xu D, Wang C, Jin J, Zhou L. Dapagliflozin activates neurons in the Central Nervous System and regulates Cardiovascular activity by inhibiting SGLT-2 in mice. Diabetes Metab Syndr Obes. 2020;13:2781–99.PubMedPubMedCentralCrossRef Nguyen T, Wen S, Gong M, Yuan X, Xu D, Wang C, Jin J, Zhou L. Dapagliflozin activates neurons in the Central Nervous System and regulates Cardiovascular activity by inhibiting SGLT-2 in mice. Diabetes Metab Syndr Obes. 2020;13:2781–99.PubMedPubMedCentralCrossRef
45.
go back to reference Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia. BMC Res Notes. 2016;9:78.PubMedPubMedCentralCrossRef Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia. BMC Res Notes. 2016;9:78.PubMedPubMedCentralCrossRef
46.
go back to reference Zhu HT, Yu M, Hu H, He QF, Pan J, Hu RY. Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study. BMC Endocr Disord. 2019;19(1):57.PubMedPubMedCentralCrossRef Zhu HT, Yu M, Hu H, He QF, Pan J, Hu RY. Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study. BMC Endocr Disord. 2019;19(1):57.PubMedPubMedCentralCrossRef
47.
go back to reference Cheng LJ, Wang W, Lim ST, Wu VX. Factors associated with glycaemic control in patients with diabetes mellitus: a systematic literature review. J Clin Nurs. 2019;28(9–10):1433–50.PubMedCrossRef Cheng LJ, Wang W, Lim ST, Wu VX. Factors associated with glycaemic control in patients with diabetes mellitus: a systematic literature review. J Clin Nurs. 2019;28(9–10):1433–50.PubMedCrossRef
48.
go back to reference da Silva Moreira FGD, Almeida S, de Souza Teles M, Andrade CA, Reingold CS, Moreira AL Jr. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela. BMJ Open. 2019;9(3):e023401.PubMedPubMedCentralCrossRef da Silva Moreira FGD, Almeida S, de Souza Teles M, Andrade CA, Reingold CS, Moreira AL Jr. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela. BMJ Open. 2019;9(3):e023401.PubMedPubMedCentralCrossRef
49.
go back to reference Wang S, Ji X, Zhang Z, Xue F. Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China.Int J Environ Res Public Health2020, 17(15). Wang S, Ji X, Zhang Z, Xue F. Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China.Int J Environ Res Public Health2020, 17(15).
50.
go back to reference Peng K, Chen G, Liu C, Mu Y, Ye Z, Shi L, Zhao J, Chen L, Li Q, Yang T, et al. Association between smoking and glycemic control in diabetic patients: results from the risk evaluation of cAncers in chinese diabeTic individuals: a lONgitudinal (REACTION) study. J Diabetes. 2018;10(5):408–18.PubMedCrossRef Peng K, Chen G, Liu C, Mu Y, Ye Z, Shi L, Zhao J, Chen L, Li Q, Yang T, et al. Association between smoking and glycemic control in diabetic patients: results from the risk evaluation of cAncers in chinese diabeTic individuals: a lONgitudinal (REACTION) study. J Diabetes. 2018;10(5):408–18.PubMedCrossRef
51.
go back to reference Hsieh DY, Hung JW, Chang KC, Huang YC, Lee TH, Chen HM. Malnutrition in Acute Stroke Patients stratified by Stroke Severity- A Hospital based study. Acta Neurol Taiwan. 2017;26(3):120–7. Hsieh DY, Hung JW, Chang KC, Huang YC, Lee TH, Chen HM. Malnutrition in Acute Stroke Patients stratified by Stroke Severity- A Hospital based study. Acta Neurol Taiwan. 2017;26(3):120–7.
53.
go back to reference Foley NC, Martin RE, Salter KL, Teasell RW. A review of the relationship between dysphagia and malnutrition following stroke. J Rehabil Med. 2009;41(9):707–13.PubMedCrossRef Foley NC, Martin RE, Salter KL, Teasell RW. A review of the relationship between dysphagia and malnutrition following stroke. J Rehabil Med. 2009;41(9):707–13.PubMedCrossRef
54.
go back to reference Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707–8.PubMedCrossRef Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707–8.PubMedCrossRef
55.
go back to reference Jung HS. Clinical implications of glucose variability: chronic complications of diabetes. Endocrinol Metab (Seoul). 2015;30(2):167–74.PubMedCrossRef Jung HS. Clinical implications of glucose variability: chronic complications of diabetes. Endocrinol Metab (Seoul). 2015;30(2):167–74.PubMedCrossRef
56.
go back to reference Shen Y, Zhou J, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Horswell R, Bazzano AN, Nigam S, Hu G. Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes. Diabetes Obes Metab. 2021;23(1):125–35.PubMedCrossRef Shen Y, Zhou J, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Horswell R, Bazzano AN, Nigam S, Hu G. Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes. Diabetes Obes Metab. 2021;23(1):125–35.PubMedCrossRef
Metadata
Title
Association between initial in-hospital heart rate and glycemic control in patients with acute ischemic stroke and diabetes mellitus
Authors
Ya-Wen Kuo
Jiann-Der Lee
Chuan-Pin Lee
Yen-Chu Huang
Meng Lee
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01325-2

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine